Professional Documents
Culture Documents
(
n
g
/
m
l
)
n i r e h t u e l e o s i n i r e h t u e l e e l c i h e v
h 4 2
h 8 4
0 1
0
0 1
1
0 1
2
0 1
3
0 1
4
% 6 . 3
0 1
0
0
F
L
2
-
H
F
L
2
-
H
F
L
2
-
H
1
1
0 1
2
0 1
3
0 1
4
0
1
0
0
1
1
0
1
2
0
1
3
0
1
4
0
1
0
0
1
1
0
1
2
0
1
3
0
1
4
0
1
0
0
1
1
0
1
2
0
1
3
0
1
4
% 2 . 3
0 1
0
0 1
1
0 1
2
0 1
3
0 1
4
% 8 . 0 1
n i r e h t u e l e o s i n i r e h t u e l e
I
F
N
e l c i h e v
C
Fig. 2. Stimulation of IFNc production from Th cells by isoeleutherin. Isolated CD4+
Th cells were incubated with 10 lM concentration of either eleutherin or iso-
eleutherin concomitantly with TCR stimulation. Supernatants were collected from
24 to 48 h stimulated Th cells for measuring cytokines, IL-2 (A) and IFNc (B). (C)
Monensine was added to the activated Th cells 2 h prior to harvest and collected for
intracellular cytokine staining. Activated Th cells were incubated with PE-anti-IFNc
Ab followed by ow cytometric analysis.
J.-H. Hong et al. / Biochemical and Biophysical Research Communications 371 (2008) 278282 279
(1% FBS in PBS) and analyzed by FACS Calibur (BD Biosciences). Cell populations
were measured by CellQuest software (Tree Star, Ashland, OR). For intracellular
cytokine staining, monensine (2 lM) was treated to the activated Th cells for 2 h
prior to harvest.
ELISA. Cytokines were measured by ELISAas instructedinBDPharmingen. Briey,
culture supernatants were collected fromTh cells activated for 24 and 48 h and incu-
bated oncapture Ab-coated ELISAplate. Biotinylated anti-cytokine Abs and phospha-
tase-conjugated streptavidin were sequentially incubated after plate washing and
developed with phosphatase substrate. Color changes were read by ELISA plate read-
er (Molecular Devices, Palo Alto, CA). Puried and known concentrations of IL-2 and
IFNc were incubated parallel with unknown samples for standard curves.
Isolation of total RNA and real-time PCR. Total RNA was isolated fromthe activated
Th cells treated by using the RNeasy Mini Kit (Qiagen, Hilden, Germany) and treated
with DNase to remove any remnant genomic DNA. cDNA was reverse transcribed
from2 lg of total RNA by Superscript rst strand synthesis system(Invitrogen, Carls-
bad, CA) and used for quantitative real-time PCR using SYBR Green PCR master with
an ABI PRISM7000 Sequence Detection System(Applied Biosystems, Foster City, CA).
The following primers were used: b-actin-FWD 5
0
-aagcaggagtatgacgagtccg-3
0
, b-ac-
tin-REV 5
0
-cggaactaagtcatagtccgcc-3
0
; IFNc-FWD 5
0
-agcaacagcaaggcgaaaa-3
0
, IFNc-
REV 5
0
-ctggacctgtgggttgttga-3
0
; IL-2-FWD 5
0
-ctcctgagcaggatggagaatt-3
0
, IL-2-REV
5
0
-cgcagaggtccaagtgtagct-3
0
; T-bet-FWD 5
0
-cccccaaggaattgacagttg-3
0
, T-bet-REV 5
0
-
gggaaactaaagctcacaaac-3
0
; IL-4-FWD 5
0
-ggcattttgaacgaggtcaca-3
0
, IL-4-REV 5
0
-
aggacgtttggcacatccat-3
0
.
Results and discussions
Pyranonaphthoquinones affect CD4+ Th cell activation and
proliferation in vitro
A variety numbers of naphthopyran derivatives have been iden-
tied and grouped based on their structural moiety and are known
to have anti-fungal and anti-tumor functions [1,5,79]. Structures
of eleutherin, isoeleutherin, and eleutherinol are shown in Fig.
1A. While eleutherin and isoeleutherin are structurally epimeric
isomers derived from 1,4-naphthoquinone moiety, eleutherinol
(8,10-dihydroxy-2,5-dimethyl-4H-naphtho[1,2-b]-pyran-4-one)
contains naphthopyran-4-one moiety, which is different from 1,4-
naphthoquinone (Fig. 1A). We have treated these compounds with
different doses in Th cells, and assessed the activation and prolifer-
ation of Th cells upon TCR stimulation. Both eleutherin and
isoeleutherin partially inhibited cell proliferation at 30 lM concen-
tration, although there was no effect at lower concentration (Fig.
1B). However, Th cell proliferation upon TCR activation was not
at all affected by eleutherinol. Decreased cell populations by treat-
ment of naphthopyran derivatives prompted us to inspect the ef-
fects on cell apoptosis. Annexin V staining and ow cytometric
analyses determined that both eleutherin and isoeleutherin in-
creased apoptosis at 30 lM, but eleutherinol rarely induced apop-
totic cell death (Fig. 1C). These results indicated that 1,4-
naphthoquinone moiety in eleutherin and isoeleutherin may have
selective functions on cell apoptosis, remaining further studies on
the functional mechanisms. Since the high concentration of pyr-
anonaphthoquinones induced cell apoptosis, we chose lowconcen-
tration of naphthopyran derivatives for further studies.
Eleutherin and isoeleutherin differentially modulate IFNc production
in CD4+ Th cells upon TCR stimulation
In order to examine the effects of eleutherin and isoeleutherin
on Th cell activation and differentiation, we assessed cytokines
A
N F I
B t e b - T
r
e
l
a
t
i
v
e
t
r
a
n
s
c
r
i
p
t
s
(
x
1
0
-
2
)
0
5 . 0
1
5 . 1
2
5 . 2
0 3 0 1 0 3 0 1 0
n i r e h t u e l e o s i n i r e h t u e l e
(M)
0
1
2
3
4
0 3 0 1 0 3 0 1 0
n i r e h t u e l e o s i n i r e h t u e l e
(M)
r
e
l
a
t
i
v
e
t
r
a
n
s
c
r
i
p
t
s
(
x
1
0
-
2
)
C
D
e l c i h e v n i r e h t u e l e o s i
0 1
0
0 1
1
0 1
2
0 1
3
0 1
4
% 1 . 4 1
0 1
0
0 1
1
0 1
2
0 1
3
0 1
4
FL4-H FL4-H
% 5 . 4
n i r e h t u e l e
0 1
0
0 1
1
0 1
2
0 1
3
1 0 1
4
0
1
0
0
1
1
0
1
2
0
1
3
1
0
1
4
FL4-H
F
L
2
-
H
0
1
0
0
1
1
0
1
2
0
1
3
1
0
1
4
F
L
2
-
H
0
1
0
0
1
1
0
1
2
0
1
3
1
0
1
4
F
L
2
-
H
% 0 . 4
0
3
6
9
2 1
5 1
8 1
I
F
N
(
n
g
/
m
l
)
0
1
2
+ - n i r e h t u e l e o s i
t e b - T
+ / +
+ -
t e b - T
- / -
t e b - T
- / -
s n
I
F
N
Fig. 3. T-bet-dependent IFNc modulation mediated by isoeleutherin. Th cells were stimulated with anti-CD3 and anti-CD28 for 48 h with eleutherin or isoeleutherin as
indicated. Total RNA was isolated from the activated Th cells and used for determination of IFNc (A) and T-bet (B). (C) CD4+ Th cells were isolated from wild type C57BL6 and
T-bet knockout/B6 mice and stimulated with anti-CD3 and anti-CD28 concomitant with (+) or without () isoeleutherin (10 lM) for 48 h. Supernatants were collected for
measuring IFNc by ELISA. IFNc produced in T-bet-decient CD4+ Th cells is shown in the box with enlarged scale. Statistical signicance was indicated as ns (not signicant).
(D) TCR-triggered Th cells were incubated with 10 lM of compounds for 4 days and subsequently restimulated with PMA and ionomycin for 4 h. Cells were harvested and
stained for analyzing IFNc-producing cell populations.
280 J.-H. Hong et al. / Biochemical and Biophysical Research Communications 371 (2008) 278282
productions in Th cells upon treatment. Since TCR triggering signif-
icantly stimulated cytokine productions in CD4+ Th cells, both IL-2
and IFNc were comparatively increased in cell supernatants. Treat-
ment of 10 lM of either eleutherin or isoeleutherin in Th cells
seemed to have no effect on IL-2 production (Fig. 2A). Under the
same conditions, IFNc was signicantly increased by isoeleutherin
at 24 and 48 h post-TCR stimulation, but not induced by eleutherin
(Fig. 2B). Moreover, the intracellular cytokine staining showed con-
sistently increased IFNc-producing cell populations by isoeleuther-
in treatment, but not affected by eleutherin (Fig. 2C), insisting that
isoeleutherin may be a specic stimulator of IFNc production. Iso-
eleutherin has only one different chiral center from the structure of
eleutherin. Therefore, the activity of isoeleutherin seems to be dee-
ply related with the chirality at its pyran ring with the a-methyl
functionality.
Isoeleutherin activated IFNc gene transcription by the induction of
T-bet, a master Th1-specic transcription factor
Cytokines are critically regulated at the level of gene transcrip-
tion by specic transcription factors. IFNc production in Th cells is
known to be critically regulated by T-bet, a Th1-specic transcrip-
tion factor, which directly binds to IFNc gene promoter and enhan-
cer and plays a key role in Th1 cell differentiation. Quantitative
real-time PCR of IFNc and T-bet conrmed that isoeleutherin in-
creased both IFNc and T-bet gene transcription in dose-dependent
manner (Fig. 3A and B), suggesting that isoeleutherin modulates
IFNc expression in Th cells in T-bet-dependent manner. In order
to conrm the T-bet-dependent IFNc modulation by isoeleutherin,
we used T-bet-decient CD4+ Th cells, which decreased IFNc pro-
duction due to T-bet-deciency. Isoeleutherin increased IFNc pro-
duction in wild type Th cells, but failed to stimulate IFNc
expression in the absence of T-bet (Fig. 3C), insisting on the mech-
anism that isoeleutherin modulate IFNc production in T-bet-
dependent manner. Moreover, Th cell differentiation was more
prominently committed into Th1 cell lineages in the presence of
isoeleutherin (Fig. 3D), supporting the efcient modulator of
Th1-mediated immune responses of isoeleutherin.
Eleutherinol inhibits IL-2 and IFNc productions by suppressing gene
transcriptions
Eleutherinol possesses a naphthopyran-4-one moiety, which is
distinguished from 1,4-naphthoquinone moiety found in eleuther-
in and isoeleutherin as shown in Fig. 1A. As high concentration of
eleutherinol did not induce cell apoptosis, we measured the cyto-
kine productions during Th cell activation. Interestingly, IL-2 and
IFNc productions were signicantly impaired as the concentrations
of eleutherinol increased (Fig. 4A and B). Decreased cytokine pro-
ductions resulted from the reduced gene transcription levels of
IL-2 and IFNc by eleutherinol (Fig. 4C and D), whereas IL-4 gene
transcription was not reduced by eleutherinol, suggesting the
selective inhibition of IL-2 and IFNc (Fig. 4F). Moreover, semi-
quantitative RT-PCR convinced the impaired mRNA levels of cyto-
kines, which was mediated by eleutherinol (Fig. 4E).
Current studies of the effects of naphthopyran derivatives on Th
cell activation claried the critical function of isoeleutherin as a
stimulant of Th1 immune response and also uncovered novel
inhibitory functions of eleutherinol on cytokine productions during
Th cell activation. These ndings partly explain the mechanism
how E. americana were used as a folk medicine for treating micro-
bial infections and tumor. We strongly suggest that modulation of
0 3 0 1 0
(M) l o n i r e h t u e l e
0
2
4
6
8
0 1
I
F
N
(
n
g
/
m
l
)
A
0
2
4
6
8
0 1
2 1
4 1
6 1
8 1
I
L
-
2
(
n
g
/
m
l
)
0 3 0 1 0
l (M) o n i r e h t u e l e
h 4 2
h 8 4
B
0 3 0 1 0
(M) l o n i r e h t u e l e
0
4 0 . 0
8 0 . 0
2 1 . 0
N F I
0 3 0 1 0
(M) l o n i r e h t u e l e
r
e
l
a
t
i
v
e
t
r
a
n
s
c
r
i
p
t
s
t
o
-
a
c
t
i
n
(
x
1
0
-
2
)
1
2
3
4
0
1
2
4
3
5
0
2 - L I
r
e
l
a
t
i
v
e
t
r
a
n
s
c
r
i
p
t
s
t
o
-
a
c
t
i
n
D C
0 3 0 1 0
l (M) o n i r e h t u e l e
r
e
l
a
t
i
v
e
t
r
a
n
s
c
r
i
p
t
s
t
o
-
a
c
t
i
n
(
x
1
0
-
3
)
4 - L I
F E
2 - L I
N F I
n i t c a -
0 3 0 1 0
l (M) o n i r e h t u e l e
Fig. 4. Effects of eleutherinol on cytokine productions during Th cell activation. Th cells were co-incubated with eleutherinol with the indicated amount and time period and
supernatants were used for measuring cytokines, IFNc (A) and IL-2 (B). Activated Th cells were harvested for the isolation of total RNA and used for determination of IFNc (C),
IL-2 (D), and IL-4 (F). (D) Semi-quantitative RT-PCR was performed to detect IFNc and IL-2 in Th cells treated with eleutherinol and PCR products were resolved by agarose gel
electrophoresis.
J.-H. Hong et al. / Biochemical and Biophysical Research Communications 371 (2008) 278282 281
immune responses by pyranonaphthoquinone derivatives may
contribute to anti-tumor and anti-microbial activities.
Acknowledgments
This work was supported by Ewha Womans University Re-
search Grant of 2005, National R&D program for Cancer Control
of National Cancer Center (0620380) and in part by NCRC program
of MOST and KOSEF (R15-2006-020). T-bet-decient mice were
kindly provided by Dr. Laurie H. Glimcher at Harvard University.
References
[1] Y.Q. Li, M.G. Li, W. Li, J.Y. Zhao, Z.G. Ding, X.L. Cui, M.L. Wen, Griseusin D, a new
pyranonaphthoquinone derivative from a alkaphilic Nocardiopsis sp.,
J. Antibiot. (Tokyo) 60 (2007) 757761.
[2] L.M. Tewierik, C. Dimitriadis, C.D. Donner, M. Gill, B. Willems, Total synthesis of
enantiopure 1,3-dimethylpyranonaphthoquinones including ventiloquinones
E, G, L and eleutherin, Org. Biomol. Chem. 4 (2006) 33113318.
[3] T.M. Alves, H. Kloos, C.L. Zani, Eleutherinone, a novel fungitoxic
naphthoquinone from Eleutherine bulbosa (Iridaceae), Mem. Inst. Oswaldo
Cruz 98 (2003) 709712.
[4] S. El-Hady, J. Bukuru, B. Kesteleyn, L. Van Puyvelde, T.N. Van, N. De Kimpe, New
pyranonaphthoquinone and pyranonaphthohydroquinone from the roots of
Pentas longiora, J. Nat. Prod. 65 (2002) 13771379.
[5] M.A. Brimble, L.J. Duncalf, M.R. Nairn, Pyranonaphthoquinone antibiotics
isolation, structure and biological activity, Nat. Prod. Rep. 16 (1999) 267281.
[6] C. Bianchi, G. Ceriotti, Chemical and pharmacological investigations of
constituents of Eleutherine bulbosa (Miller) Urb. (Iridaceae), J. Pharm. Sci. 64
(1975) 13051308.
[7] S. Kumar, W.P. Malachowski, J.B. Duhadaway, J.M. Lalonde, P.J. Carroll, D. Jaller,
R. Metz, G.C. Prendergast, A.J. Muller, Indoleamine 2,3-dioxygenase is the
anticancer target for anovel series of potent naphthoquinone-based inhibitors,
J. Med. Chem. 51 (2008) 17061718.
[8] S.H. Lagorio, D.A. Bianchi, E.G. Sutich, T.S. Kaufman, Synthesis and
antimicrobial activity of pyranobenzoquinones related to the
pyranonaphthoquinone antibiotics, Eur. J. Med. Chem. 41 (2006) 13331338.
[9] P. Krishnan, K.F. Bastow, Novel mechanism of cellular DNA topoisomerase II
inhibition by the pyranonaphthoquinone derivatives alpha-lapachone and
beta-lapachone, Cancer Chemother. Pharmacol. 47 (2001) 187198.
[10] L.B. Nielsen, D. Wege, The enantioselective synthesis of elecanacin through an
intramolecular naphthoquinone-vinyl ether photochemical cycloaddition, Org.
Biomol. Chem. 4 (2006) 868876.
[11] B. Weniger, M. Haag-Berrurier, R. Anton, Plants of Haiti used as antifertility
agents, J. Ethnopharmacol. 6 (1982) 6784.
[12] S.A. Afanasev, T.V. Lasukova, A.M. Cherniavskii, I. Vecherskii, I.V.
Ponomarenko, The effect of histochrome on the lipid peroxidation indices
during the surgical treatment of patients with ischemic heart disease of
different functional classes, Eksp. Klin. Farmakol. 62 (1999) 3234.
[13] D.M. Anwar-Bruni, S.E. Hogan, D.A. Schwartz, C.M. Wilcox, R.T. Bryan, J.L.
Lennox, Atovaquone is effective treatment for the symptoms of
gastrointestinal microsporidiosis in HIV-1-infected patients, AIDS 10 (1996)
619623.
[14] J. Xu, F. Qiu, G. Qu, N. Wang, X. Yao, Studies on antifungal constituents isolated
from Eleutherine americana, Zhongguo Yaowu Huaxue Zazhi 15 (2005) 157
161.
[15] P. Krishnan, K.F. Bastow, Novel mechanisms of DNA topoisomerase II
inhibition by pyranonaphthoquinone derivatives-eleutherin, alpha
lapachone, and beta lapachone, Biochem. Pharmacol. 60 (2000)
13671379.
[16] S. Romagnani, Type 1 T helper and type 2 T helper cells: functions, regulation
and role in protection and disease, Int. J. Clin. Lab. Res. 21 (1991) 152158.
[17] B. Spellberg, J.E. Edwards Jr., Type 1/Type 2 immunity in infectious diseases,
Clin. Infect. Dis. 32 (2001) 76102.
[18] S.B. Cameron, E.H. Stolte, A.W. Chow, H.F. Savelkoul, T helper cell polarisation
as a measure of the maturation of the immune response, Mediators Inamm.
12 (2003) 285292.
[19] C. Dong, R.A. Flavell, Cell fate decision: T-helper 1 and 2 subsets in immune
responses, Arthritis Res. 2 (2000) 179188.
[20] U. Syrbe, J. Siveke, A. Hamann, Th1/Th2 subsets: distinct differences in homing
and chemokine receptor expression?, Springer Semin. Immunopathol. 21
(1999) 263285.
[21] M.A. Skinner, S. Yuan, R. Prestidge, D. Chuk, J.D. Watson, P.L. Tan,
Immunization with heat-killed Mycobacterium vaccae stimulates CD8+
cytotoxic T cells specic for macrophages infected with Mycobacterium
tuberculosis, Infect. Immun. 65 (1997) 45254530.
[22] M. Zhou, W. Ouyang, The function role of GATA-3 in Th1 and Th2
differentiation, Immunol. Res. 28 (2003) 2537.
[23] S.J. Szabo, S.T. Kim, G.L. Costa, X. Zhang, C.G. Fathman, L.H. Glimcher, A novel
transcription factor, T-bet, directs Th1 lineage commitment, Cell 100 (2000)
655669.
[24] S.J. Szabo, B.M. Sullivan, C. Stemmann, A.R. Satoskar, B.P. Sleckman, L.H.
Glimcher, Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma
production in CD4 and CD8 T cells, Science 295 (2002) 338342.
282 J.-H. Hong et al. / Biochemical and Biophysical Research Communications 371 (2008) 278282